Cutler Group LP Selecta Biosciences Inc Put Options Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Oct 27, 2020	SELL	$2.18 - $2.84 $436 - $568	-200 Reduced 11.11%	1,600 $0
Q2 2020 Jul 22, 2020	BUY	$1.83 - $4.06 $1,464 - $3,247	800 Added 80.0%	1,800 $1,000
Q4 2018 Feb 05, 2019	BUY	$2.66 - $15.93 $2,660 - $15,930	1,000 New	1,000 $9,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.